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 Summary 
 Pursuant to General Assembly resolution 68/300, the present report sets out the 
progress achieved since 2014 in the implementation of the outcome document of the 
high-level meeting of the General Assembly on the comprehensive review and 
assessment of the progress achieved in the prevention and control of 
non-communicable diseases and of the political declaration of the high -level meeting 
of the Assembly on the prevention and control of non-communicable diseases, in 
preparation for a comprehensive review and assessment in 2018 of the progress 
achieved in the prevention and control of non-communicable diseases. 
 In the report, it is underscored that action to realize the commitments made in 2011 
and 2014 is inadequate, that the current level of progress is insufficient to meet target 
3.4 of the Sustainable Development Goals on non-communicable diseases and that the 
world has yet to fulfil its promise of implementing measures to reduce the risk of dying 
prematurely from non-communicable diseases through prevention and treatment.  
 Initiatives to improve access to good-quality essential health-care services and 
to safe, effective, good-quality and affordable essential medicines and vaccines for the 
prevention and control of non-communicable diseases have not been scaled up in the 
majority of developing countries. Political commitments have often not been translated 
into concrete action. Serious constraints driven by economic and trade promotion 
interests are impeding the implementation by many Governments of some of the “best 
buys” and other recommended interventions for the prevention and control of 
non-communicable diseases, including the taxation of tobacco, alcohol and sugar-
sweetened beverages and policies to reduce the impact on children of the marketing of 
foods and non-alcoholic beverages high in saturated fats, trans-fatty acids, free sugars 
or salt. There is also a visible gap in respect of each country’s policy space and 
leadership to establish and implement policies for the prevention and control of 
non-communicable diseases. 
 
 * The present report was submitted late so as to include the most recent information.  
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 Through the monitoring of progress since 2011, it has been shown that, despite 
the modest financing requirements and the cost-effectiveness of interventions, funding 
for national programmes from domestic resources and international finance is still 
grossly insufficient in developing countries. The level of official deve lopment 
assistance to catalyse additional resource mobilization from other sources has 
remained close to zero since 2011. While there are undeniable examples of progress, 
such progress is patchy and will not have a significant impact in terms of reaching 
target 3.4.  
 Given the outstanding deficits, it is crucial to reach agreements on a new strategic 
course and approach to support countries in implementing the “best buys” and other 
recommended interventions, strengthening health systems, engaging the private sector 
and measuring progress towards target 3.4.  
 Going forward, delivering on the world’s promises will require an innovative 
way of finding new development pathways that effectively address impediments and 
at the same time encourage creativity and innovation. Such an effort must be 
accompanied with a reshaping of the ways of working together and the leveraging of 
genuine partnerships and inclusive action that make full use of existing expertise, 
technology and resources in supporting the implementation of the “best buys” and 
other recommended interventions.  
 The present report is intended to serve as a first reference for the broader 
consultations to take place. 
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  Prevention and control of non-communicable diseases 
 
 
 I. Introduction 
 
 
1. The present report is submitted pursuant to paragraph 38 of the outcome 
document of the high-level meeting of the General Assembly on the comprehensive 
review and assessment of the progress achieved in the prevention and control of 
non-communicable diseases, held on 10 and 11 July 2014 (General Assembly 
resolution 68/300). In that document, ministers and representatives of States and 
Governments and heads of delegations requested the Secretary-General, in 
collaboration with Member States, the World Health Organization (WHO) and 
relevant funds, programmes and specialized agencies of the United Nations system, 
to submit to the Assembly, by the end of 2017, for consideration by Member States, 
a report on the progress achieved in the implementation of the outcome document and 
of the political declaration of the high-level meeting of the Assembly on the 
prevention and control of non-communicable diseases, in preparation for a 
comprehensive review, in 2018, of the progress achieved in the prevention and control 
of non-communicable diseases. 
2. The progress achieved from 2011 to 2013 is summarized in the third report of 
the Director-General of WHO on the prevention and control of non-communicable 
diseases (see A/68/650), which should be read in conjunction with the present report.  
3. The present report provides an overview of the progress achieved since the 
adoption of the outcome document, including national efforts (sect. II), global action 
to accelerate national efforts (sect. III) and recommendations (sect. IV). 
4. The progress achieved by the United Nations Inter-Agency Task Force on the 
Prevention and Control of Non-communicable Diseases is summarized in its reports 
to the Economic and Social Council of 2014, 2015, 2016 and 2017 (see E/2014/55, 
E/2015/53, E/2016/53 and E/2017/54). The corresponding resolutions of the Council, 
resolutions 2014/10, 2015/8, 2016/5 and 2017/8, should be read in conjunction with 
the present report. 
 
 
 II. National efforts 
 
 
  Where the world stands today 
 
5. Premature deaths from non-communicable diseases are one of the major 
challenges for development in the twenty-first century, leaving no country untouched. 
A total of 15 million people aged from 30 to 70 died from non-communicable diseases 
in 2015. The number of women and men who die prematurely from 
non-communicable diseases continues to rise disproportionately in low-income and 
lower-middle-income countries, where, in 2015, 47 per cent (7 million) of the 
premature deaths from non-communicable diseases occurred, as shown in table 1.  
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  Table 1 
  Premature deaths from non-communicable diseases, 2015 
  (Among individuals aged from 30 to 70)  
 
 Women (millions) Men (millions) Total (millions) Percentage 
     
Low-income countries 0.4  0.4  0.8  6 
Lower-middle-income countries 2.6  3.6  6.2  41 
Upper-middle-income countries 2.4  3.5  5.9  39 
High-income countries 0.8  1.3  2.1  14 
 Total 6.2  8.8  15.0  100 
 
 
6. As premature deaths from non-communicable diseases are largely preventable, 
the 15 million deaths among individuals aged from 30 to 70 in 2015 should be viewed 
in the context of the 12 million preventable deaths from communicable diseases and 
perinatal conditions and the 5 million from injuries and violence in the same year.1  
7. Globally, the risk of dying prematurely from non-communicable diseases among 
individuals aged from 30 to 70 declined from 23 per cent in 2000 to 19 per cent in 
2015.2 The decline was mainly due to the reduction in the number of deaths from 
cardiovascular and chronic respiratory diseases. While the risk declined  in both 
developed and developing countries, the decline was much steeper in developed 
countries.3 In 2015, the risk of dying prematurely from non-communicable diseases 
among individuals aged from 30 to 70 ranged from 8 per cent in some of the richest 
countries to 36 per cent in some of the poorest countries . 
8. Within countries at all levels of development, non-communicable diseases affect 
the poorest people and those furthest behind in particular, and their increased  risk of 
dying prematurely from non-communicable diseases is, therefore, a marker of the 
devastating impact of the high burden of non-communicable diseases on the lives of 
the poor, their untold suffering and the threat to sustainable development.  
9. In order to reach target 3.4 of the Sustainable Development Goals (by 2030, 
reduce by one third premature mortality from non-communicable diseases through 
prevention and treatment and promote mental health and well -being), the existing 
political commitments made at the General Assembly in 2011 and 2014 need to be 
implemented on a dramatically higher scale. Without a significant scaling up of 
efforts before 2020, the current rate of decline in the risk of dying prematurely from 
non-communicable diseases is insufficient to meet the target by 2030.   
10. Premature deaths from non-communicable diseases among individuals aged 
from 30 to 70 can be largely prevented or delayed by implementing a set of 16 “best 
buys”, which are considered to be the most cost-effective and feasible interventions 
for implementation in developing countries, and 72 other recommended interventions, 
which have proved to be effective for the prevention and control of 
__________________ 
 1  Data available from www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html . 
 2  World Health Organization (WHO), World Health Statistics 2017: Monitoring Health for the 
Sustainable Development Goals (2017). Available from www.who.int/gho/publications/ 
world_health_statistics/2017/en/. 
 3  Graduate Institute of International and Development Studies and WHO, “The NCD challenge: 
where do we stand today? How did we get to 2011? What happened in 2014? How are we getting 
to 2018?”, background paper, para. 4. Available from www.who.int/nmh/events/2017/  
background-paper-for-the-ncd--who-gi-meeting-final.pdf?ua=1. 
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non-communicable diseases, as endorsed by the World Health Assembly in its 
resolution WHA70.11 in 2017. Together, these 88 interventions, which have been 
outlined in full by WHO,4 range from increasing excise taxes on tobacco products and 
alcoholic beverages to providing drug therapy and counselling to persons who have 
had a heart attack or stroke, or to persons who are at a moderate to high risk of having 
such an event in the next 10 years, and include the vaccination of girls aged from 9 
to 13 against human papillomavirus and the prevention of cervical cancer by 
screening women aged from 30 to 49. While prevention is key and can prevent from 
one half to two thirds of premature deaths from non-communicable diseases, effective 
health care can prevent from one third to one half of premature deaths, and investing 
in better management of the four major non-communicable diseases is an essential 
component of any national response to non-communicable diseases.5  
 
  Achievements measured against the agreed scorecard 
 
11. In the outcome document of 2014, it was recognized that some progress had 
been achieved at the national level since 2011 but that overall progress had been 
insufficient and highly uneven. In paragraph 30 of the outcome document, Member 
States committed themselves to taking the following four time-bound measures: 
 (a) By 2015, consider setting national targets for 2025 and process indicators 
based on national situations, taking into account the nine voluntary global targets for 
non-communicable diseases; 
 (b) By 2015, consider developing or strengthening national multisectoral 
policies and plans to achieve the national targets by 2025, taking into account the 
Global Action Plan for the Prevention and Control of Non-communicable Diseases 
2013–2020; 
 (c) By 2016, as appropriate, reduce risk factors for non-communicable 
diseases and underlying social determinants through the implementation of 
interventions and policy options to create health-promoting environments, building 
on the guidance set out in appendix 3 to the Global Action Plan;  
 (d) By 2016, as appropriate, strengthen and orient health systems to address 
the prevention and control of non-communicable diseases and the underlying social 
determinants through people-centred primary health care and universal health 
coverage throughout the life cycle, building on the guidance set out in appendix 3 to 
the Global Action Plan.  
12. The Director-General of WHO published a technical note on 1 May 2015, 
updated on 4 September 2017, setting out a scorecard for each Member State to 
measure the implementation of those time-bound commitments.6  
13. The progress measured against that scorecard is shown in table 2.  
  
__________________ 
 4  WHO, “Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and 
control of non-communicable diseases”, 2017. Available from http://apps.who.int/iris/bitstream/  
10665/259232/1/WHO-NMH-NVI-17.9-eng.pdf?ua=1. 
 5  See www.who.int/nmh/events/un_ncd_summit2011/qa/overview_brochure.pdf?ua=1 . 
 6  WHO, Noncommunicable Diseases Progress Monitor 2017 (Geneva, 2017). Available from 
www.who.int/nmh/publications/ncd-progress-monitor-2017/en/. 
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  Table 2 
  Progress in the implementation of the commitments measured against 
the scorecard 
 
 
Number of Member 
States  
Indicator 2015 2017 
Increase 
(percentage) 
    
Member States that have set national targets to address 
non-communicable diseases 59 93 58 
Member States that have established operational multisectoral 
strategies to address non-communicable diseases 64 94 48 
Member States that have developed guidelines for managing 
the four major non-communicable diseases 50 90 80 
 
 
14. Notwithstanding those areas of improvement, overall progress in the 
implementation of the time-bound commitments remains far below the bar set in 
2014. In 2017, 138 Member States demonstrated very poor or no progress towards 
implementing the time-bound commitments. The scorecard was launched during a 
side event at the beginning of the general debate of the seventy-second session of the 
General Assembly. Tracked against 19 indicators, the overall score for each Member 
State is given in the Noncommunicable Diseases Progress Monitor 2017, with a full 
explanation of the methodology used, using data collected in the first half of 2017.7 
 
  Impediments to progress by Member States in reaching target 3.4 of the 
Sustainable Development Goals 
 
15. Current efforts to implement “best buys” and other recommended interventions for 
the prevention and control of non-communicable diseases continue to lack the scale 
necessary to accelerate progress towards target 3.4, in particular in low- and lower-middle 
income countries. Obstacles to progress at the national level are described in table 3. 
 
Table 3 
Challenges to the implementation of the “best buys” and other recommended interventions for the 
prevention and control of non-communicable diseases 
 
Challenge Obstacles Political responsibility  
   Political choices  – Weak political action by Heads of State and Government to 
integrate the prevention and control of non-communicable 
diseases into national responses to the 2030 Agenda for 
Sustainable Development 
Heads of State and 
Government 
  – With the exception of a few, Member States did not include 
progress towards target 3.4 of the Sustainable Development 
Goals in their voluntary national reviews of 2016 and 2017 at 
the high-level political forum on sustainable development of 
the Economic and Social Council, which is not coherent with 
the acknowledgement by Heads of State and Government in 
2011 that non-communicable diseases constituted one of the 
 
__________________ 
 7  Ibid. 
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Challenge Obstacles Political responsibility  
   major challenges for development in the twenty-first century 
(see General Assembly resolution 66/2, annex, para. 1) 
  – In increasing numbers, high-income and upper-middle-
income Member States are pursuing policy coherence 
among economic goals and interests, the trade-related 
Sustainable Development Goals and target 3.4 in national 
responses to the 2030 Agenda. Low-income and lower-
middle-income countries have no capacity to make such 
trade-offs when developing national responses to the 
Sustainable Development Goals 
 
Health systems  – Lack of access for all to affordable, safe, effective and 
good-quality essential medicines and vaccines for 
non-communicable diseases 
Ministers of health 
  – The implementation of the WHO package of essential 
non-communicable disease interventions for primary health 
care in low-resource settingsa and other packages is scattered 
across primary health-care entities and lacks sufficient impact 
 
  –  “Best buys” and other recommended interventions for the 
prevention and control of non-communicable diseases are 
insufficiently integrated into national universal health 
coverage packages provided by the public sector  
 
  – Health systems in the poorest developing countries do not have 
the capacity required to integrate the “best buys” and other 
recommended interventions for the prevention and control of 
non-communicable diseases into primary health care, referral 
services, human resources and monitoring systems 
 
  – Limited progress towards target 3.8 of the Sustainable 
Development Goals on achieving universal health coverage 
 
National capacities  – Most low-income and lower-middle-income countries have 
no policy backbone or advanced technical expertise for the 
prevention and control of non-communicable diseases 
 – Most Member States have no capacity to establish cross-
sectoral partnerships for the prevention and control of 
non-communicable diseases or to manage the complexity of 
such partnerships during the implementation of national 
responses to non-communicable diseases 
Ministers of commerce, 
finance, health and trade 
  
  – The development of proposals to increase the price of and 
introduce tax-related measures on tobacco, alcohol and 
sugar-sweetened beverages as an effective and important 
way of reducing consumption and health-care costs and 
generating a national revenue stream, as well as catalysing 
other financing streams, requires appropriate skill sets, 
which are not available in most low-income and lower-
middle-income countries 
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Challenge Obstacles Political responsibility  
     – Most Member States lack the capacity to find common 
ground between policymakers and private sector entities in 
the prevention and control of non-communicable diseases 
and to convert such consensus into new public health 
approaches 
 
International finance  – Despite the commitments made in 2011, members of the 
Development Assistance Committee of the Organization for 
Economic Cooperation and Development (OECD) have not 
made the prevention and control of non-communicable 
diseases a priority in bilateral development cooperation. 
The level of official development assistance to catalyse 
additional resource mobilization from other sources, for 
example, from the taxation of tobacco, alcohol and sugar-
sweetened beverages, or unlock additional finance through 
blended or pooled financing remains almost zero  
Ministers of health, 
finance, planning and 
development cooperation 
  – Demands for technical cooperation from the poorest 
developing countries to support national efforts to 
implement the “best buys” and other recommended 
interventions are largely unmet, owing mainly to the lack of 
international financing to strengthen the capacity of WHO 
and the United Nations Inter-Agency Task Force on the 
Prevention and Control of Non-communicable Diseases to 
expand the delivery of technical assistance. The programme 
area responsible for the prevention and control of 
non-communicable diseases at WHO has been chronically 
underfunded since 2011 and is currently (in percentage 
terms) the most underfunded programme area in the WHO 
programme budget 
 
  – In June 2017, the Economic and Social Council, in its 
resolution 2017/8, noted that the four global joint 
programmes developed by the Task Force remained 
unfunded to date, recognized that the Task Force’s support 
to Member States to reflect the targets relating to 
non-communicable diseases in the 2030 Agenda in national 
development plans and policies could not be fulfilled with 
the current resources and urged bilateral donors to 
strengthen development assistance for non-communicable 
diseases, in particular with regard to legal, fiscal and 
regulatory systems, including for evidence-based strategies 
such as taxation. The situation, however, remains 
unchanged since June 2017 
 
  – International development cooperation and national 
responses to non-communicable diseases are still not 
aligned, despite continued requests from low-income and 
lower-middle-income countries. In such countries, there is 
a lack of projects that can be submitted to international 
financing institutions for their consideration and of skills to 
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Challenge Obstacles Political responsibility  
   engage with public and private financing partners, in 
particular the World Bank and regional development banks, 
in order to make project financing proposals for national 
responses to non-communicable diseases, which is a major 
impediment to greater investment by international 
financing institutions in initiatives to address non-
communicable diseases 
Industry interference  – Industry interference impedes the implementation of the 
“best buys” and other recommended interventions, 
including the taxation of tobacco, alcohol and sugar-
sweetened beverages 
 – Multinationals with vested interests routinely interfere with 
health policymaking, including by lobbying against the 
implementation of recommended interventions, working to 
discredit proven science and pursuing legal challenges to 
oppose progress. In some instances, such efforts are 
actively supported by other countries, such as through 
international trade disputes. Industry interference is one of 
the commercial determinants of health, a concept that 
extends to governmental policies and practices such as 
trade promotionb 
Ministers of commerce, 
finance, development 
cooperation, economic 
affairs and trade 
  
  – Countries hosting headquarters of multinationals that have 
the largest market share in exporting cigarettes, alcoholic 
beverages and sugar-sweetened beverages to low- and 
middle-income countries rely on those multinationals to 
“responsibly market” their health-harming products in other 
countries 
 
  – High-income countries show limited interest in reflecting in 
their international development cooperation the 
interconnectedness of promoting economic goals and 
promoting health as two mutually reinforcing policies in 
terms of achieving the Sustainable Development Goals  
 
  – Some Member States consider that it is not the role of the 
organizations of the United Nations system to advocate 
particular outcomes in legal challenges related to 
non-communicable diseases between Member States or 
between a Member State and a private sector entityc 
 
 
 a WHO, Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low -Resource 
Settings (Geneva, 2010). Available from www.who.int/cardiovascular_diseases/publications/pen2010/en. 
 b The commercial determinants of health are the commercial conditions, actions and omissions that affect health. Commercial 
determinants arise in the context of the provision of goods or services for payment and include commercial activities, as wel l 
as the environment in which commerce takes place. Commercial determinants can have a beneficial and/or detrimental imp act 
on health. 
 c See, for example, the statement of the Government of the United States of America on the Montevideo Road Map 2018–2030 
on Non-Communicable Diseases as a Sustainable Development Priority. Available from www.who.int/conferences/global-ncd-
conference/statements/en.  
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 III. Global action to accelerate national efforts  
 
 
  2030 Agenda for Sustainable Development 
 
16. In July 2015, Heads of State adopted the Addis Ababa Action Agenda of the 
Third International Conference on Financing for Development, in which they 
recognized that, as part of a comprehensive strategy of prevention and control, price 
and tax measures on tobacco could be an effective and important means to reduce 
tobacco consumption and health-care costs and represented a revenue stream for 
financing for development in many countries (see General Assembly resolution 
69/313, annex, para. 32). In a study by WHO, it was shown that at least 30 countries 
had chosen to earmark tobacco tax revenues for health purposes. 8 
17. In September 2015, Heads of State adopted the 2030 Agenda for Sustainable 
Development, which includes target 3.4 of the Sustainable Development Goals on 
non-communicable diseases. The target derives directly from the global target 
adopted by the World Health Assembly in its resolution WHA66.10 in 2013 relating 
to a relative reduction of 25 per cent in overall mortality from cardiovascular diseases, 
cancer, diabetes or chronic respiratory diseases by 2025. In that resolution, the World 
Health Assembly noted that the target concerned premature mortality from 
non-communicable diseases between ages 30 and 70. 
18. In its resolution 70/259, the General Assembly decided to proclaim 2016–2025 
the United Nations Decade of Action on Nutrition, conscious of the need, inter alia, 
to reverse the rising trends in overweight and obesity and reduce the burden of diet-
related non-communicable diseases. The Food and Agriculture Organization of the 
United Nations and WHO are leading on its implementation.  
 
  World Health Organization 
 
19. To support Member States in their efforts, WHO prioritized, from 2014 to 2018, 
its technical support to Member States to help them to achieve the nine voluntary 
global targets for 2025 for the prevention and control of non-communicable diseases, 
adopted by the World Health Assembly in its resolution WHA66.10 in May 2013, as 
part of the WHO Global Action Plan for the Prevention and Control of 
Non-communicable Diseases 2013–2020. 9 When reached collectively by Member 
States by 2025, the targets will help Member States to achieve target 3.4 of t he 
Sustainable Development Goals on non-communicable diseases by 2030. In order to 
accelerate action on preventing non-communicable diseases from 2019 to 2023, 
taking into account that progress from 2013 to 2018 has been largely insufficient, 
WHO will establish a platform to work with Member States and other partners in 
scaling up efforts to prioritize the implementation of interventions to reach the 
following set of intermediate targets for 2023:  
 (a)  A relative reduction of 25 per cent in the overall mortality from 
cardiovascular diseases, cancer, diabetes and chronic respiratory diseases;  
 (b)  A relative reduction of 25 per cent in the prevalence of current tobacco use 
in persons aged 15 years and over; 
__________________ 
 8  WHO, “The economic and health benefits of tobacco taxation”, 2015. Available from 
www.who.int/fctc/mediacentre/news/2015/WHOTobaccoReport.pdf . 
 9  See www.who.int/nmh/publications/ncd-action-plan/en/. 
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 (c)  A relative reduction of 10 per cent in the harmful use of alcohol, as 
appropriate, within the national context;  
 (d)  A relative reduction of 25 per cent in the mean population intake of 
salt/sodium; 
 (e)  Halt and begin to reverse the rise in childhood overweight (0–4 years) and 
obesity (5–19 years); 
 (f)  Eliminate industrially produced trans fats (increase the percentage of 
people protected by effective regulation);  
 (g)  Reduce physical inactivity among persons aged 18 years and over from 
28 per cent (2016) to 26 per cent (2023).10  
20. To scale up its support in those areas, WHO has developed technical assistance 
packages, which are presented in table 4.  
 
  Table 4 
Technical assistance packages of the World Health Organization  
 
Package  Objective 
  MPOWERa  Reduce the demand for tobacco in line with the 
demand reduction provisions of the WHO 
Framework Convention on Tobacco Control  
HEARTSb  Scale up cardiovascular disease management in 
primary health care 
SHAKEc  Reduce population salt intake 
Implementation package for the WHO Global 
Strategy to Reduce the Harmful Use of Alcohold  
Reduce the harmful use of alcohol 
Package of essential non-communicable disease 
interventionse  
Integrate essential non-communicable disease 
interventions into primary health care 
Commission on Ending Childhood Obesity f  Reduce childhood obesity 
Essential Nutrition Actionsg  Address malnutrition in all its forms  
Mental Health Gap Action Programme 
intervention guide 
Increase service coverage for severe mental 
health disorders 
 
 a See www.who.int/tobacco/mpower/en/. 
 b See www.who.int/cardiovascular_diseases/hearts/en/ . 
 c WHO, The SHAKE Technical Package for Salt Reduction (Geneva, 2016). Available from www.who.int/ 
dietphysicalactivity/publications/shake-salt-habit/en/. 
 d See www.who.int/nmh/ncd-tools/alcohol-use/en/. 
 e See www.who.int/ncds/management/pen_tools/en/. 
 f See www.who.int/end-childhood-obesity/en/. 
 g WHO, Essential Nutrition Actions: Improving Maternal, Newborn, Infant and Young Child Health and 
Nutrition (Geneva, 2013). Available from www.who.int/nutrition/publications/infantfeeding/  
essential_nutrition_actions/en/. 
__________________ 
 10  WHO, “Draft thirteenth general programme of work 2019–2023”. Available from 
www.who.int/about/what-we-do/gpw13-expert-group/Draft-GPW13-Advance-Edited-
5Jan2018.pdf?ua=1. 
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21. The assignments given to WHO by the General Assembly in 2014 and the World 
Health Assembly since 2014 have resulted in a number of assignments being 
completed before the third high-level meeting in 2018, as reflected in table 5.  
 
Table 5 
Assignments given to the World Health Organization by the General Assembly and the World Health Assembly  
 
Assignment Date of completion Outcome 
   Update appendix 3 to the Global Action 
Plan for the Prevention and Control of 
Non-communicable Diseases 2013–2020 
(i.e. the “best buys” and other 
recommended interventions for the 
prevention and control of 
non-communicable diseases) 
May 2017a  Provide guidance to Member States on how to 
strengthen national responses to 
non-communicable diseases 
Develop an implementation plan for the 
report of the WHO Commission on 
Ending Childhood Obesity 
May 2017b  Provide guidance to Member States on how to 
strengthen national responses to 
non-communicable diseases 
Develop a global action plan to promote 
physical activityc  
November 2017 Provide guidance to Member States on how to 
strengthen national responses to 
non-communicable diseases 
Develop an approach that can be used to 
register and publish contributions of 
non-State actors to the achievement of the 
nine voluntary global targets for 
non-communicable diseases  
Phase 1: 2016d  
Phase 2: 2017e  
Phase 3: pending 
Provide a platform to track self-reported 
contributions from non-governmental 
organizations, the private sector, philanthropic 
foundations and academic institutions to the 
implementation of national responses to 
non-communicable diseases, using a common set 
of comparable indicators and an assessment, 
which is independently verifiable  
Through the Development Assistance 
Committee of OECD, develop a purpose 
code for non-communicable diseases in 
order to track official development 
assistance for non-communicable diseases 
June 2017 Track official development assistance for 
technical support to strengthen national 
responses to non-communicable diseases 
Conduct a midpoint evaluation of 
progress on the implementation of the 
WHO Global Action Plan for the 
Prevention and Control of 
Non-Communicable Diseases 2013–2020f  
Pending (2018) Take stock of lessons learned and recommend 
corrective actions 
Conduct a preliminary evaluation of the 
WHO Global Coordination Mechanism 
on the Prevention and Control of Non-
Communicable Diseases to assess its 
results and added valueg  
Ongoing Take stock of lessons learned and recommend 
corrective actions, if any  
 
A/72/662 
 
13/28 17-22646 
 
Assignment Date of completion Outcome 
   Organize the first global meeting of 
national non-communicable disease 
directors and programme managersh  
February 2016 Supported national non-communicable disease 
directors in identifying solutions to address 
bottlenecks in realizing the four time-bound 
commitments  
 
 a The updated appendix 3 was endorsed by the seventieth World Health Assembly and is available in WHO document A70/27, 
annex 1, p. 8. Available from http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_27-en.pdf. 
 b The implementation plan was welcomed by the seventieth World Health Assembly in WHO document A70/31. Available from 
http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_31-en.pdf. 
 c WHO, “Physical activity for health: more active people for a healthier world — draft global action plan on physical activity 
2018–2030”, discussion paper, December 2017. Available from www.who.int/ncds/governance/physical_activity_plan/en/ . 
 d See WHO document A69/10, annex 4, p. 26. Available from http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_10-en.pdf. 
 e See WHO document A70/27, annex 2, p. 25.  
 f Ibid., para. 20. 
 g Ibid., para. 21. 
 h See www.who.int/nmh/events/2016/ncd-focal-points/en/. 
 
 
22.  In preparation for 2018, WHO, in collaboration with the Graduate Institute of 
International and Development Studies in Geneva, organized a meeting of 
international experts and global advocates on 8 and 9 June 2017 to share ideas about 
priority actions to reinforce collective global action on non-communicable diseases. 
The meeting resulted in a report with recommendations for Member States, WHO and 
stakeholders, which may serve as an input into the preparatory process leading to th e 
comprehensive review and assessment in 2018.11 
23. WHO organized the Global Conference on Non-Communicable Diseases, held 
in Montevideo from 18 to 20 October 2017, with the participation of Member States, 
organizations of the United Nations system, civil society, the private sector, 
philanthropic foundations and academic institutions. Participants from Member 
States attending the Conference adopted the Montevideo Road Map 2018–2030 on 
Non-Communicable Diseases as a Sustainable Development Priority, 12 which may 
serve as an input into the preparatory process leading to the high-level meeting in 
2018.  
24. The Director-General of WHO established the WHO Independent Global High-
level Commission on Non-communicable Diseases in October 2017, inter alia, to 
make recommendations that may contribute to the preparatory process leading to the 
comprehensive review and assessment in 2018.13 The Commission will issue its first 
report with recommendations in May 2018. The Director-General also established the 
WHO civil society working group to make bold and practical recommendations on 
mobilizing civil society in a meaningful manner to enable a highly successful high -
level meeting that proves to be a tipping point for the non-communicable disease and 
mental health response.14  
 
__________________ 
 11  Graduate Institute of International and Development Studies and WHO, “The NCD challenge: 
current status and priorities for sustained action on the road to 2030 (Geneva, 8–9 June 2017)”, 
2017. Available from www.who.int/nmh/events/2017/ncd-challenge/en/. 
 12  See www.who.int/montevideo2017. 
 13  See www.who.int/ncds/governance/third-un-meeting/en/. 
 14  See www.who.int/ncds/governance/high-level-meetings/working-group-third-high-level-
meeting/en/. 
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  Global Coordination Mechanism on the Prevention and Control of 
Non-Communicable Diseases of the World Health Organization  
 
25. The sixty-seventh World Health Assembly endorsed the terms of reference of 
the Global Coordination Mechanism on the Prevention and Control of 
Non-Communicable Diseases. 15  Workplans covering the periods 2014–2015,  
2016–2017 and 2018–2019 were submitted to the World Health Assembly in 2015, 
2016 and 2017, respectively. 16  Progress reports were submitted to the WHO 
governing bodies in 2016 and 2018. An extended progress report covering the period 
2014–2016 was published in October 2017.17  
26. The Global Coordination Mechanism has organized dialogues, which are 
presented in table 6. 
 
Table 6 
Dialogues of the Global Coordination Mechanism on the Prevention and Control of 
Non-Communicable Diseases 
 
Date Question addressed Main conclusions  
   April 2015 How to encourage the continued 
inclusion of non-communicable 
diseases in development 
cooperation agendas and 
initiativesa  
 – Improve analysis of the effect of non-communicable 
diseases on the poorest 20 per cent of the population  
 – Shape the non-communicable disease narrative into one 
of poverty and inequity 
 – Map the supply and demand of technical assistance for 
non-communicable diseases 
 – Call for catalytic official development assistance (to be 
provided through aid and expertise) to develop national 
responses to non-communicable diseases and build 
capacity for domestic resource mobilization (e.g., 
through tobacco taxes) 
April 2016 How to strengthen international 
cooperation on non-communicable 
diseases within the framework of 
North-South, South-South and 
triangular cooperationb  
 – Integrate non-communicable diseases into existing 
national health programmes (e.g., HIV/AIDS, 
tuberculosis, reproductive health) and avoid a siloed 
approach to non-communicable diseases 
 – Build national investment cases for non-communicable 
diseases 
__________________ 
 15  See WHO document A67/14 Add.1, appendix 1. 
 16  WHO document A67/14 Add.3 Rev.1, available from http://apps.who.int/gb/ebwha/pdf_files/  
WHA67/A67_14Add3Rev1-en.pdf; WHO document A68/11, annex 3, available from 
http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_11-en.pdf; WHO document A70/27, annex 3. 
 17  WHO, “WHO global coordination mechanism on the prevention and control of 
non-communicable diseases: progress report 2014–2016”, Geneva, 2017. Available from 
www.who.int/global-coordination-mechanism/news/progress-report14-16/en/. 
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Date Question addressed Main conclusions  
   October 2016 The role of non-governmental 
organizations, the private sector, 
philanthropic foundations and 
academic institutions in supporting 
Member States in their efforts to 
tackle non-communicable diseasesc  
 – Deepen the understanding of the differences in the roles 
that non-State actors, such as non-governmental 
organizations, the private sector, philanthropic 
foundations and academic institutions, can play in 
contributing to a whole-of-society national response to 
non-communicable diseases 
   – Acknowledge the diversity of the private sector, 
including its resources, knowledge and ingenuity  
   – Make clear calls to non-governmental organizations, the 
private sector, philanthropic foundations and academic 
institutions on how to contribute to national responses to 
non-communicable diseases 
 
 a WHO, “Report of the first dialogue convened by the World Health Organization Global Coordination Mechanism on 
Noncommunicable Diseases”, Geneva, 2015. Available from www.who.int/global-coordination-
mechanism/final_meeting_report_dialogue_ncd_development_april15_en.pdf?ua=1 . 
 b WHO, “Dialogue on how to strengthen international cooperation on noncommunicable diseases within the framework of 
North-South, South-South and triangular cooperation: second dialogue convened by the World Health Organization Global 
Coordination Mechanism on Noncommunicable Diseases”, 2016. Available from www.who.int/global-coordination-
mechanism/publications/dialogue-report-nov-dec-2015.pdf?ua=1. 
 c WHO, “Working together to tackle noncommunicable diseases: Global Coordination Mechanism on Noncommunicable 
Diseases global dialogue meeting on the role of non-State actors in supporting Member States in their national efforts to tackle 
noncommunicable diseases as part of the 2030 Agenda for Sustainable Development”, final report, 2016. Available from 
www.who.int/global-coordination-mechanism/dialogues/global-dialogue-meeting-report-oct2016.pdf?ua=1. 
 
 
27. The co-chairs of the dialogue on the role of non-State actors in supporting 
Member States in their national efforts to tackle non-communicable diseases as part 
of the 2030 Agenda, held in Mauritius from 19 to 21 October 2016, issued a statement 
clarifying the roles of non-State actors in supporting Governments and national 
efforts to reach target 3.4 of the Sustainable Development Goals on 
non-communicable diseases, which may serve as an input into the preparatory process 
leading to the comprehensive review in 2018.18  
28. The Global Coordination Mechanism has established four working groups, the 
work of which is presented in table 7.  
 
  
__________________ 
 18  Available from www.who.int/global-coordination-mechanism/dialogues/global-dialogue-
meeting-2030-agenda-for-sustainable-development/en/. 
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Table 7 
Working groups of the Global Coordination Mechanism on the Prevention and Control of 
Non-Communicable Diseases 
 
Year Question addressed Main recommendations  
   2016  How Governments can engage with the private 
sector to:  
– Implement the set of recommendations of 
WHO to reduce the impact of the marketing 
of food and non-alcoholic beverages to 
children 
– Produce and promote more products that are 
consistent with a healthy diet 
– Promote healthy behaviours among workers 
in the workplace 
– Reduce the use of salt in the food industry  
– Improve access to affordable medicines for 
non-communicable diseasesa 
– The Government sets national targets for 
non-communicable diseases and develops national 
responses to non-communicable diseases, and the 
private sector contributes to their implementation  
 – Analyse the rationale, principles, benefits and risks 
of encouraging the private sector to protect and 
promote public health and contribute to the 
attainment of national targets on non-communicable 
diseases 
 – Manage the risks of engagement, including conflicts 
of interest 
 – Build a strong regulatory framework, ranging from 
statutory to self-regulatory, to align private sector 
incentives with public-health goals and national 
targets for non-communicable diseases 
 – Establish a robust mechanism to publish and register 
commitments and contributions that are specific, 
measurable, achievable, relevant and time-bound 
 – Establish a multi-stakeholder platform to track the 
implementation of national targets for 
non-communicable diseases 
 – Exchange data to support collective global action  
2016 How Governments can provide funding for 
national responses to non-communicable 
diseases through domestic, bilateral and 
multilateral channelsb 
– Establish taxes on health-harming products, such as 
tobacco and sugar-sweetened beverages, as a revenue 
stream to finance national responses to the 
Sustainable Development Goals, including national 
responses to non-communicable diseases 
  – Seek official development assistance to catalyse 
resource mobilization from domestic sources, both 
public and private. For instance, catalytic official 
development assistance can support improved 
tobacco tax collection or be used to unlock blended 
or pooled financing for the implementation of 
national responses to non-communicable diseases 
2016 
and 
2017 
How Governments can include the prevention 
and control of non-communicable diseases in 
responses to HIV/AIDS, tuberculosis, 
reproductive health and maternal and child 
healthc  
– Build a national business case for integration  
– Integrate the prevention and control of non-
communicable diseases into primary care  
– Train the health workforce in task-sharing 
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Year Question addressed Main recommendations  
   – Use mobile health and other innovative technologies  
– Establish a high-level commission to oversee the 
integration 
2016 
and 
2017 
How Governments can align international 
cooperation with national responses to 
non-communicable diseasesd  
– Integrate national responses to non-communicable 
diseases into national responses to the Sustainable 
Development Goals 
  – Establish an international cooperation framework to 
mobilize official development assistance for 
non-communicable diseases as part of national 
responses to the 2030 Agenda 
  – Promote policy coherence to attain target 3.4 of the 
Sustainable Development Goals on 
non-communicable diseases 
  – Prioritize evidence-based advocacy to mobilize all 
stakeholders 
 
 a WHO, “WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: final report and 
recommendations from the working group on ways and means of encouraging Member States and non -State actors to realize 
the commitment included in paragraph 44 of the political declaration of the high-level meeting of the United Nations General 
Assembly on the prevention and control of non-communicable disease”. Available from www.who.int/global-coordination-
mechanism/working-groups/final_3_1report_with_annexes_6may16.pdf?ua=1. 
 b WHO, “WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Disea ses: final report and 
recommendations from the working group on ways and means of encouraging Member States and non -State actors to realize the 
commitment included in paragraph 45 (d) of the political declaration of the high-level meeting of the United Nations General 
Assembly on the prevention and control of non-communicable diseases”. Available from www.who.int/global-coordination-
mechanism/working-groups/final_5_1with_annexes6may16.pdf?ua=1. 
 c WHO, “WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: interim report 
with preliminary recommendations from the working group on the integration of NCDs in  other programmatic areas (WG 3.1, 
2016–2017)”. Available from www.who.int/global-coordination-mechanism/working-groups/working-group-3-1/en/. 
 d WHO, “WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: interim report 
with preliminary recommendations from the working group on alignment of international cooperation with national NCD 
plans”. Available from www.who.int/global-coordination-mechanism/working-groups/working-group-3-2/en/. 
 
 
29. On the occasion of the high-level political forum on sustainable development of 
the Economic and Social Council in 2016, the Global Coordination Mechanism 
launched a global communications campaign to raise awareness of the feasibility of 
reducing premature deaths from non-communicable diseases.19  
 
  United Nations Inter-Agency Task Force on the Prevention and Control of 
Non-communicable Diseases and its members 
 
30. The Economic and Social Council, in paragraph 1 of its resolution 2013/12, 
requested the Secretary-General to establish the United Nations Inter-Agency Task 
Force on the Prevention and Control of Non-communicable Diseases by expanding 
the mandate of the existing Ad Hoc Inter-Agency Task Force on Tobacco Control. 
Pursuant to that request, the Task Force was convened and is led by WHO, reports to 
the Council through the Secretary-General and incorporates the work of the Ad Hoc 
__________________ 
 19  See www.who.int/beat-ncds/en/. 
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Inter-Agency Task Force on Tobacco Control, including the work to support the 
accelerated implementation by parties to the WHO Framework Convention on 
Tobacco Control. 
31. The aim of the United Nations Inter-Agency Task Force on the Prevention and 
Control of Non-communicable Diseases is to coordinate the activities of the relevant 
United Nations funds, programmes and specialized agencies and other 
intergovernmental organizations to support the realization of the commitments made 
by Heads of State and Government in the political declaration of the high -level 
meeting of the General Assembly on the prevention and control of non-communicable 
diseases of 2011 (see General Assembly resolution 66/2, annex). 
32. Pursuant to the terms of reference of the Task Force, WHO provides a secretariat 
to lead efforts to build a strategic coalition of United Nations organizations and other 
international organizations to ensure a United Nations development system that is fit 
for purpose to strengthen national efforts to reach target 3.4 of the Sustainable 
Development Goals on non-communicable diseases and target 3.a on tobacco.20  
33. The Task Force has harnessed system-wide action to support Governments in 
the integration of non-communicable diseases into national responses to the 2030 
Agenda. In 2017, more than 60 per cent of the United Nations agencies that are 
members of the Task Force reported that they had included non-communicable 
diseases in their mandates, which is an increase from the 30 per cent reported in 
2014.21 At the national level, there has been a year-to-year increase in the number of 
countries that have included non-communicable diseases in their United Nations 
Development Assistance Frameworks.  
34. The Task Force has responded to requests to organize joint programming 
missions to Bahrain, Barbados, Belarus, Bhutan, Cambodia, the Democratic Republic 
of the Congo, Ethiopia, India, Kenya, Kuwait, Kyrgyzstan, Mongolia, Mozambique, 
Oman, Paraguay, Saudi Arabia, Sri Lanka, Tonga, Turkey, the United Arab Emirates, 
Viet Nam and Zambia to support United Nations country teams in scaling up their 
technical assistance to Governments to develop and implement national responses to 
non-communicable diseases. Up to 17 United Nations agencies participated in each 
mission, together with the resident United Nations country teams. The missio ns have 
resulted in prioritized and costed national responses to non-communicable diseases, 
national investment cases and fiscal, legislative and regulatory policies.  
35. A number of United Nations organizations have collaborated in the development 
of global joint programmes to provide technical support to countries. Examples of 
programmes and projects taken forward by the organizations are described in more 
detail in the workplans of the Task Force and their reviews. 22  
36. The Task Force has also provided support for the ratification and 
implementation of the WHO Framework Convention on Tobacco Control. A model 
policy has been developed for United Nations agencies to prevent tobacco industry 
__________________ 
 20  WHO, “Terms of reference for the UN Interagency Task Force on the Prevention and Control of 
Noncommunicable Diseases”, Geneva, 2015. Available from www.who.int/ncds/un-task-
force/ToR_UNIATF.pdf?ua=1. 
 21  WHO, “How NCDs are reflected in governing body policies, strategies and plans”, 7 March 
2017. Available from www.who.int/ncds/un-task-force/ncds-governingbodypolicies-
7march2017.pdf?ua=1. 
 22  See www.who.int/ncds/un-task-force/en/.  
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interference in order to ensure consistent and effective separation between the 
activities of the United Nations system and the tobacco industry.  
37. The World Bank continues to support countries that wish to finance national 
responses to non-communicable diseases through loans. The Task Force has also 
provided a platform to mobilize resources for the work of its members. Japan and the 
Russian Federation have provided funds to scale up the technical assistance provided 
by the Task Force. 
38.  The International Telecommunication Union and WHO, which have been 
working since 2013 to help Governments to use mobile phones to implement national 
responses to non-communicable diseases, currently support 10 countries with text -
messaging services for diabetes, cervical cancer and tobacco cessation. There are 
close to 3 million users, and early results indicate good health outcomes.  
 
  World Health Organization Framework Convention on Tobacco Control  
 
39. With 181 State parties, the WHO Framework Convention on Tobacco Control is 
one of the treaties with the most ratifications in the history of the United Nations, 
covering more than 90 per cent of the world’s population. 
40. At the seventh session of the Conference of the Parties to the Convention, held 
in Delhi in November 2016, 30 decisions were adopted, together with the Delhi 
Declaration, in which, inter alia, the parties were called upon to prevent interference 
by the tobacco industry. The decisions include the strengthening of synergies between 
the Conference of the Parties and the World Health Assembly and the contribution of 
the Conference of the Parties to the achievement of the voluntary global target for 
2025 of a relative reduction of 30 per cent in the prevalence of current tobacco use in 
persons aged 15 years and over. 
41. The Protocol to Eliminate Illicit Trade in Tobacco Products, the first protocol to 
the Convention, was adopted in 2012 at the fifth session of the Conference of the 
Parties. At present, seven ratifications are required to bring the Protocol into force.  
 
  Global accountability framework 
 
42. The existing global accountability framework for the prevention and control of 
non-communicable diseases was developed through separate intergovernmental 
processes led by Member States under the auspices of WHO. 23  
43. There is no agreed accountability framework to register and publish the 
contributions of non-governmental organizations, private sector entities, 
philanthropic foundations and academic institutions. WHO was called upon, in 2014, 
by the General Assembly to develop such an approach (General Assembly 
resolution 68/300, para. 37). While the contours of such an approach were noted by 
the World Health Assembly in 201624 and 2017,25 WHO has not been able to finalize 
a concrete self-reporting tool, including related indicators, that non-State actors could 
use to publish their own contributions on their own websites for independent 
comparison and assessment. WHO envisages finalizing this work before the end of 
2018, in close consultation with other organizations of the United Nations system. 
 
__________________ 
 23  See WHO document A69/10, annex 8. Available from http://apps.who.int/gb/ebwha/pdf_files/  
WHA69/A69_10-en.pdf. 
 24  Ibid., annex 4. 
 25  See WHO document A70/27, annex 2.  
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  International development agencies 
 
44. Only six members of the Development Assistance Committee of OECD have 
integrated non-communicable diseases into their bilateral and multilateral 
international development policies.  
 
  Philanthropic foundations 
 
45. Bloomberg Philanthropies has committed nearly $1 billion since 2007 to combat 
tobacco use worldwide. The Bill and Melinda Gates Foundation has committed 
$288 million since 2008 to reduce tobacco use. The funds have helped to support 
developing countries in putting in place key measures to reduce tobacco demand that 
are aligned with the Framework Convention on Tobacco Control, such as banning 
advertising, outlawing smoking in public places and taxing tobacco.  
46. Specific initiatives include: 
 (a) The Bloomberg initiative to reduce tobacco use in low- and middle-income 
countries. WHO is one of the implementing partners;  
 (b) The partnership for healthy cities to save lives by preventing 
non-communicable diseases and injuries. Supported by Bloomberg Philanthropies in 
partnership with WHO and Vital Strategies, the initiative enables cities to deliver a 
“best buy” intervention in their communities;  
 (c) The Resolve to Save Lives initiative to save 100 million individuals from 
cardiovascular disease. The initiative is housed within Vital Strategies and is funded 
with $225 million from Bloomberg Philanthropies, the Chan Zuckerberg Initiative 
and the Bill and Melinda Gates Foundation. WHO is one of the implementing 
partners. 
 
  Non-governmental organizations 
 
47. The Non-Communicable Disease Alliance, which has developed a network of 
more than 2,000 civil society organizations in more than 170 countries, aims to unite 
and strengthen civil society networks with a view to stimulating collaborative  
advocacy, action and accountability to improve the lives of people living with 
non-communicable diseases and addressing their risk factors.26 The first global forum 
of the Alliance, held in Sharjah, the United Arab Emirates, from 13 to 15 November 
2015, resulted in the adoption of the Sharjah Declaration on non-communicable 
diseases, in which the roles and responsibilities are set out for civil society, the 
business community and national and international media to reduce deaths, disability, 
stigma and discrimination caused by non-communicable diseases. 27 At the second 
global forum, held in Sharjah, the United Arab Emirates, from 9 to 11 December 2017, 
consensus was reached on advocacy priorities for the high-level meeting in 2018.28  
 
  Private sector entities 
 
48. Some private sector entities have begun to take measures to implement the set 
of recommendations of WHO on the marketing of foods and non-alcoholic beverages 
__________________ 
 26  See www.ncdalliance.org/. 
 27  Available from https://ncdalliance.org/sites/default/files/resource_files/Sharjah%20Declaration%  
20on%20NCDs%20fv%20-%20EN_0.pdf. 
 28  See https://ncdalliance.org/what-we-do/convening/global-ncda-forum-2017/objectives. 
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to children. 29  Similarly, some food manufacturers have started to work towards 
reducing salt and trans-fatty acids in food products. While an increasing number of 
private sector entities have started to produce and promote more food products that 
are consistent with a healthy diet, such food products are not affordable, accessible 
or available in most developing countries. The “City Cancer Challenge” initiative, 
which was launched in 2017 to help cities to lead in the design, planning and 
implementation of cancer treatment solutions, is already working with the cities of 
Cali, Colombia, Asunción, Paraguay, Yangon, Myanmar, and Kumasi, Ghana. The 
initiative is funded mainly by pharmaceutical and medical technology companies. 30  
49.  Private sector entities, notably banks and insurance companies, have divested 
tobacco investments and have stopped advising tobacco companies, traders and 
manufacturers owing to health concerns.  
 
 
 IV. Recommendations 
 
 
  Inflection point 
 
50. The political declaration contained in the annex to General Assembly 
resolution 66/2 is the promise of the United Nations to the poorest and most 
vulnerable people of a world free from the avoidable burden of non-communicable 
diseases, an issue that was not addressed in the Millennium Development Goals. The 
political declaration succeeded in placing non-communicable diseases on the 2030 
Agenda for Sustainable Development.  
51.  The world is reaching an inflection point. Without significant investment now, 
premature mortality from non-communicable diseases in developing countries will 
continue to increase and the world will not be able to reach target 3.4 of the 
Sustainable Development Goals on non-communicable diseases by 2030.  
 
  Paradigm shift  
 
52. There is a pressing need for bolder commitments at the General Assembly in 
2018 to ensure that all countries stand a chance of reaching target 3.4 by 2030. The 
forces that are impeding progress will remain largely unopposed unless countries 
work together and receive a higher level of support through international cooperation.  
53. A paradigm shift is needed to do things differently to address obstacles in a new 
development era. The outcome document to be adopted during the high-level meeting 
on non-communicable diseases in 2018 will need to encourage more holistic 
approaches to non-communicable diseases, within the broader global health and 
universal health coverage agenda, drawing links to other priorities and forging bold 
political consensus across the following areas:  
 (a)  How to enhance governance for non-communicable diseases at the global 
and national levels by pursuing policy coordination and coherence between public 
health and economic policies, such as in the context of the promotion of trade or 
investment, as a pathway to reach common results that contribute to the targets of the 
Sustainable Development Goals related to both trade and non-communicable 
diseases; 
__________________ 
 29  See WHO document WHA63/2010/REC1, annex 4. 
 30  See www.uicc.org/what-we-do/convening/ccan-2025-city-cancer-challenge/ccan-2025-partners. 
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 (b)  How to concentrate efforts on reducing risk factors for non-communicable 
diseases by fostering cross-sectoral collaboration and reducing the underlying social 
determinants through the implementation of the relevant “best buys” to reduce 
tobacco use, the harmful use of alcohol, unhealthy diets and physical inactivity as the 
arrowhead of any national response to non-communicable diseases; 
 (c)  How to integrate interventions to promote mental health and well-being 
into national responses to non-communicable diseases and provide treatment and care 
for people with mental health disorders within community settings;  
 (d) How to dissolve traditional, disease-specific silos to broaden universal 
health coverage approaches to include a publicly financed package of health services 
for the prevention and control of non-communicable diseases that includes the “best 
buys” and other recommended interventions;  
 (e) How to establish a more realistic and manageable set of monitoring 
requirements to measure results, building on the global monitoring framework for 
non-communicable diseases and leveraging Sustainable Development Goals review 
processes, and strengthen national surveillance systems accordingly;  
 (f) How to begin to embrace conceptually the emerging idea that revenues 
resulting from the taxation of multinational revenues from the sale of cigarettes, 
alcoholic beverages and sugar-sweetened beverages in developing countries should 
be ploughed back (through aid and expertise) to support efforts to implement national 
responses to non-communicable diseases and strengthen health systems overall;  
 (g) How to improve engagement with non-State actors, including the private 
sector and civil society, with a view to strengthening their contribution to the 
implementation of national responses to non-communicable diseases.  
54. Organizations of the United Nations system will need to support this paradigm 
shift, in particular through the United Nations Inter-Agency Task Force on the 
Prevention and Control of Non-communicable Diseases, and draw upon its 
comparative advantage to: 
 (a) Bring target 3.4 of the Sustainable Development Goals on 
non-communicable diseases and target 3.a on tobacco fully to life, in particular in 
low- and lower-middle-income countries;  
 (b) Take advantage of the current focus in countries on developing national 
responses to the Sustainable Development Goals. United Nations organizations have 
a role to play in ensuring that the inclusion of target 3.4 is duly considered within 
broader efforts to strengthen health systems and achieve universal health coverage 
and that the cross-sectoral nature and co-benefits of reducing non-communicable 
diseases are well understood to advance health and well-being overall. There is a 
sense of urgency, as the window of opportunity to integrate non-communicable 
diseases into the design process and implementation of national responses to the 
Sustainable Development Goals will close by 2019 or 2020; 
 (c) Use existing global networks to create a critical mass of policymakers, 
including parliamentarians, in countries that can make a real difference during the 
next 12 to 24 months in integrating non-communicable diseases into national 
responses to the Sustainable Development Goals;  
 (d) Strengthen the talent pool and skill set of the United Nations, bring in new 
expertise and scale up its operational capacities in countries to respond to the rapidly 
increasing demand for technical assistance to reduce non-communicable diseases; 
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 (e) Reinforce the role of WHO in the leadership and coordination of the Task 
Force and as the custodian for mobilizing and monitoring global action to reach 
target 3.4; 
 (f) Strengthen collaboration across the various agencies, programmes and 
funds of the United Nations system to support whole-of-system approaches to 
accelerate progress against target 3.4;  
 (g) Strengthen the ability of the United Nations to work on some of the most 
sensitive and consequential issues at the intersection of health, economic policies, 
investment promotion, trade, law and the commercial determinants of 
non-communicable diseases. 
 
  Reinvigorating political action 
 
55.  The “best buys” and other recommended interventions provide the clearest 
guidance on how to achieve target 3.4 of the Sustainable Development Goals. Member 
States are encouraged to recognize this at the highest political level and to prioritize 
their implementation, in line with national priorities.  
56. In addition, Governments are encouraged to: 
 (a) Give greater priority to target 3.4 in national responses to Sustainable 
Development Goal 3 as a whole and in efforts to implement the 2030 Agenda;  
 (b) Accelerate the implementation of the WHO Framework Convention on 
Tobacco Control;  
 (c) Accelerate the implementation of the WHO Global Action Plan for the 
Prevention and Control of Non-communicable Diseases 2013–2020; 
 (d) Elevate the monitoring of national responses to non-communicable 
diseases to the level of Head of State or Government in interested countries to fast -
track implementation efforts. 
57. In this regard, recommendations for the United Nations system include:  
 (a) Strengthen its capacity to provide upstream policy advice to develop 
national responses to non-communicable diseases; 
 (b) Establish an Internet platform to register, publish and track specific, 
measurable, achievable, relevant and time-bound commitments by both Member 
States and non-State actors to accelerate progress against the achievement of target 
3.4, leveraging existing platforms where possible.  
 
  Strengthen health systems to respond more effectively to  
non-communicable diseases 
 
58. Target 3.8 of the Sustainable Development Goals on universal health coverage 
provides a platform that must be leveraged to ensure that health systems begin to 
respond fully to the health-care needs of those with non-communicable diseases, in 
particular in the poorest countries.  
59. Governments are encouraged to:  
 (a) Commit themselves at the level of Head of State or Government during 
the high-level meeting on non-communicable diseases in 2018 to prioritizing a whole-
of-government approach to strengthen essential public health functions, which is  a 
prerequisite for scaling up action against non-communicable diseases;  
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 (b) Develop national publicly financed benefit packages providing universal 
health coverage that include the “best buys” for non-communicable diseases and other 
recommended interventions; 
 (c) Strengthen policies for and increase the coverage of mental health services 
in line with the four objectives of the WHO comprehensive mental health action 
plan,31 to strengthen effective leadership and governance, to provide mental -health 
and social-care services, to implement strategies for promotion and prevention in 
mental health and to strengthen information systems, evidence and research for 
mental health, and provide adequate resources for such activities.  
60. In this regard, the recommendations for the United Nations system include:  
 (a) Scale up a whole-of-system approach, leveraging the United Nations 
Inter-Agency Task Force on the Prevention and Control of Non-communicable 
Diseases, together with the H6 partnership and other relevant mechanisms, to provide 
the best support to Governments in the implementation of the “best buys” and other 
recommended interventions to prevent and control non-communicable diseases and 
improve broader health and well-being; 
 (b) Update guidance, through WHO, on how to address the constraints faced 
by developing countries in reorienting health systems to respond more effectively to 
non-communicable diseases and mental health conditions;  
 (c) Strengthen institutional capacity to develop and implement national 
responses to non-communicable diseases. 
 
  Increase significantly financing for national responses to  
non-communicable diseases 
 
61. There was an insignificant increase in official development assistance for the 
prevention and control of non-communicable diseases from 2011 to 2017. More 
financing for national responses to non-communicable diseases is imperative and 
must be commensurate with the global health and socioeconomic levies that such 
diseases impose on economies and societies. 
62. It will take time to increase domestic and international financing for national 
responses to non-communicable diseases and mental health, and Member States need 
first to build their capacity in policy development to integrate non-communicable 
diseases into national responses to the overall implementation of the 2030 Agenda. 
Governments are encouraged to:  
 (a) Explore possible lending from the World Bank and regional development 
banks to finance national responses to non-communicable diseases; 
 (b) Explore other innovative financing approaches to leverage development 
assistance, as has been done by the Global Fund to Fight AIDS, Tuberculosis and 
Malaria, the Global Financing Facility in support of Every Woman, Every Child, and 
Gavi, the Vaccine Alliance;  
 (c) Create the fiscal space for interventions that have the capacity to generate 
revenue, such as the taxation of tobacco products, alcohol and sugar-sweetened 
beverages, and that represent a revenue for financing development, in line with 
national priorities. 
__________________ 
 31 See www.who.int/mental_health/action_plan_2013/en/. 
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63. Members of the Development Assistance Committee of OECD are also 
encouraged to integrate non-communicable diseases into their more comprehensive 
bilateral and multilateral international development policies.  
64. In this regard, the recommendations for the United Nations system include that:  
 (a) WHO and the United Nations Development Programme scale up support 
to Governments under the “Non-communicable disease 2030: action beyond health” 
initiative to build national investment cases for achieving target 3.4 of the Sustainable 
Development Goals; 
 (b) The Global Fund to Fight AIDS, Tuberculosis and Malaria, Gavi, the 
Vaccine Alliance, the Global Financing Facility in Support of Every Woman, Every 
Child and other relevant mechanisms further encourage and scale up financing for 
national responses that address comorbidities with non-communicable diseases; 
 (c) WHO develop a global business case for the prevention and control of 
non-communicable diseases, including a global investment framework for their 
prevention and control. 
 
  Redouble efforts to engage sectors beyond health  
 
65. Health gains to reduce premature deaths from non-communicable diseases can 
be achieved much more readily by influencing public policies in sectors beyond 
health than by making changes in health policy alone.  
66. Governments are encouraged to: 
 (a) Establish policies in the food system in line with the framework for action 
of the second International Conference on Nutrition32 to improve the availability of 
and access to healthy diets and restrict the supply and marketing of foods and 
non-alcoholic beverages that contribute to unhealthy diets;  
 (b) Invest in the promotion and protection of and support for breastfeeding as 
an action that addresses both under- and overnutrition;33  
 (c) Create and maintain environments that promote and safeguard the rights 
of all people of all ages to have equitable access to safe places and spaces in their 
cities and communities in which to engage in regular physical activity, according to 
ability. 
67. In this regard, recommendations for organizations of the United Nations system 
include: 
 (a) Conduct a review of the international experience of whole-of-government 
and whole-of-society approaches to achieve target 3.4 of the Sustainable 
Development Goals; 
 (b) Include non-communicable diseases in United Nations Development 
Assistance Frameworks and mobilize resources to implement action on 
non-communicable diseases; 
__________________ 
 32  Food and Agriculture Organization of the United Nations, “Conference outcome document: 
framework for action”, document ICN2 2014/3 Corr.1. Available from www.fao.org/3/a-
mm215e.pdf. 
 33  WHO, “Double-duty actions for nutrition”, document WHO/NMH/NHD/17.2. Available from 
www.who.int/iris/bitstream/10665/255414/1/WHO-NMH-NHD-17.2-eng.pdf?ua=1. 
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 (c) Scale up and broaden legal assistance to Member States to advocate 
particular outcomes in legal challenges related to non-communicable diseases 
between Member States or between a Member State and a private sector entity;  
 (d) Examine how countries can pursue and promote gender-based approaches 
to the prevention and control of non-communicable diseases; 
 (e) Establish synergies with the implementation of the United Nations Decade 
of Action on Nutrition (2016–2025) and the Global Strategy for Women’s, Children’s 
and Adolescents’ Health (2016–2030) of Every Woman, Every Child 34  and other 
relevant strategies. 
68. In policies and regulatory frameworks, private sector incentives need to be 
aligned more closely with public health goals, including by providing incentives to 
the private sector to increase the production of healthy foods and reformulate food 
products, making them conducive to a healthy diet, as well as affordable and 
accessible. In that regard, subsidies, trade agreements, trade regulations and 
investment policies will need to be reviewed to gain a better understanding of the 
implications of such policies on premature deaths from non-communicable diseases. 
69. Governments are encouraged to strengthen their capacity to analyse the rationale, 
principles, benefits and risks of engaging with the private sector to contribute to the 
implementation of national responses to non-communicable diseases. 
70. In this regard, organizations of the United Nations system should liaise with 
national and international regulatory authorities to minimize industry interference, 
which is one of the commercial determinants of health, a concept that extends to 
governmental policies and practices such as trade promotion (see table 3).  
 
  Reinforce the role of non-State actors 
 
71. Multi-stakeholder partnerships are important in complementing the efforts of 
Governments to reach the full ambition of the Sustainable Development Goals and 
should be fully leveraged to achieve target 3.4, while adequate provisions should be 
established to provide protection against conflicts of interest.  
72. Governments are encouraged to: 
 (a) Provide space for the meaningful participation of non-governmental 
organizations, the private sector, philanthropic foundations and academic institutions 
in building coalitions and alliances to contribute to the implementation of nat ional 
responses to non-communicable diseases; 
 (b) Develop and implement consumer-facing strategies, including media 
campaigns, to encourage healthier behaviours, including in relation to food 
consumption and preparation, exercise, alcohol consumption and tobacco use.  
73. In this regard, recommendations for the United Nations system include:  
 (a) Strengthen its capacity to engage with the private sector, with the 
exception of the tobacco industry, 35 taking into account the rationale, principles, 
benefits and risks of such engagement;  
__________________ 
 34  Every Woman, Every Child, “The Global Strategy for Women’s, Children’s and Adolescents’ 
Health (2016–2030)”, 2015. Available from www.everywomaneverychild.org/wp-
content/uploads/2017/10/EWEC_GSUpdate_Full_EN_2017_web-1.pdf. 
 35  In line with General Assembly resolution 66/2, para. 38, in which the Assembly recognized the 
fundamental conflict of interest between the tobacco industry and public health.  
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 (b) Encourage the private sector to use accountability frameworks with 
indicators suggested by WHO for the implementation of industry commitments for 
achieving target 3.4 of the Sustainable Development Goals;  
 (c) Encourage philanthropic foundations to include the prevention and control 
of non-communicable diseases in their country cooperation programmes;  
 (d) Encourage academic institutions to prioritize the analysis of the links 
between non-communicable diseases and broader health priorities, poverty and 
socioeconomic development in their work and capacity-building programmes. 
 
  Promote accountability to the world’s citizens 
 
74. The most effective ways to reinforce accountability are the robust and annual 
monitoring of progress in each country and the dissemination of results, including by 
using country rankings. Member States are encouraged to leverage Sustainable 
Development Goals review processes, including at the national and regional levels, 
as well as voluntary national reviews, to report their own progress against targets for 
non-communicable diseases. The annual World Health Assembly and the high-level 
political forum on sustainable development provide opportunities for regular 
reporting at the global level.  
75. There is a need to consolidate the global monitoring framework and instruments 
for reporting on the progress made since 2011 to the governing bodies of WHO, the 
Economic and Social Council and the General Assembly.  
76. In each country, a non-communicable disease risk factor survey should be 
conducted once every five years. Country-wide population-based cancer registries 
should be established or strengthened, cause-specific mortality reporting should be 
strengthened, and the performance of health systems should be assessed. 
77. An additional tool is needed to assess national capacities in the prevention and 
control of non-communicable diseases, using the joint external evaluation approach 
and taking into account existing evaluation frameworks. WHO should deve lop such 
a tool. 
78. Governments are encouraged to:  
 (a) Adopt the WHO survey methodology, which helps countries to develop 
their own surveillance system to monitor non-communicable diseases;36 
 (b) Commit themselves to adopting joint external evaluation approaches to 
assess national capacities in non-communicable diseases; 
 (c) Build reporting on non-communicable diseases into national Sustainable 
Development Goals review processes, including through voluntary national reviews 
and the leveraging of the World Health Assembly and the high-level political forum 
on sustainable development as opportunities to share progress.  
79. In this regard, recommendations for organizations of the United Nations system 
include: 
 (a) The consolidation of the WHO global monitoring framework for 
non-communicable diseases; 
__________________ 
 36  See www.who.int/ncds/surveillance/steps/en/. 
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 (b) The development by WHO of a joint external evaluation tool for 
non-communicable diseases. 
 
  Act in unity 
 
80. The inclusion of non-communicable diseases in the 2030 Agenda has provided 
the best opportunity to place non-communicable diseases at the core of humankind’s 
pursuit of shared progress. Reducing the risk of dying prematurely from 
non-communicable diseases is a challenge for all countries irrespective of the level 
of their sustainable development.  
81. Acting in unity to address non-communicable diseases demands a renewed 
commitment to work together across sectors and platforms. The United Nations 
system must also respond as one, in support of Member States’ priorities to establish 
environments and health systems that promote the full attainment of physical and 
mental health and well-being. All Member States have a responsibility to show that 
the General Assembly can be an effective governance platform in shaping a world 
free from the avoidable burden of non-communicable diseases. The bar is raised high 
for 2018, as progress since 2011 has been insufficient and highly uneven.  
 
 
 
